Pulmonaryhypertensionnews.com1d
LungFit PH NO therapy device wins marketing approval in Australia
The LungFit PH device was approved ini 2022 by the U.S. Food and Drug Administration and the European Union to treat PPHN.
Pulmonaryhypertensionnews.com4d
Imaging technique may detect earliest signs of PAH tissue changes
An imaging technique called 18F-FAPI PET may be able to detect early signs of changes in blood vessel tissues in PAH, a new ...
Pulmonaryhypertensionnews.com6d
Adempas helps lower risk in PAH patients, newer risk model confirms
A possibly more precise risk model showed Adempas helped PAH patients at intermediate risk of death arrive at more favorable ...